What a price display can tell you, and what it cannot
A medicine price list, where a clinic keeps one, carries the generic or active ingredient name, the strength, the trade name and the price per unit or per pack. That is useful. A patient is entitled to know what a medicine costs, and asking to see the list, or asking the price directly, is a reasonable question a clinic should be able to answer without friction.
What the list cannot do is stand in for an assessment. It prices a product. It says nothing about whether that product is what your skin actually needs, what the alternatives are, or how much of it a proper plan requires. Those questions belong to a diagnosis, not a price tag.
The rule, briefly, and where it stands today
Private healthcare facilities and community pharmacies in Malaysia have been required to display medicine prices under an order that took effect on 1 May 2025. That requirement has since been challenged in court: on 21 May 2026 the High Court granted private medical practitioners a stay of enforcement, pending a judicial review filed by seven organisations, the Malaysian Medical Association among them, and a private doctor. As reported in August 2026 the government has not appealed, so the stay stands; the order itself has not been revoked, but enforcement against private medical practitioners is on hold while the case continues.
That is the position as it stands, not a permanent one. The fuller account of the rule, its requirements and its history sits in the separate guide to this order, which is the place to check if the legal position has moved since this was written.
A price cannot make the decision a diagnosis makes
Knowing the exact price of a medicine tells you what it costs. It does not tell you whether you need it, whether a different treatment would suit your skin better, or whether the right answer is no treatment at all. Knowing the price of the wrong treatment, to the ringgit, protects no one. The number that matters is not on the price list. It is in the assessment that decides which treatment, if any, is right, and how much of it a plan actually calls for.
This is the same reasoning behind why a fee quoted before an assessment is a different thing from a fee that follows one: a figure attached to a guess is not more honest for being precise. A price attached to a diagnosis is.
Why this clinic assesses before it quotes
This clinic does not quote a fee before an assessment, and does not publish a price list of treatment fees, because a quote given before a consultation is a quote given before anyone has looked. A caller who wants a number first, and is told that number comes after assessment, sometimes goes elsewhere for it. That is a reasonable choice for a patient to make. It also tends to assume the treatment is already decided when it has not been, and it treats aesthetic medicine as something to be priced off a menu rather than diagnosed.
A price is legitimate information a patient may want, and asking for one is never out of place. The point is only that a price cannot substitute for the assessment that decides whether the treatment behind it is the right one.
What is worth asking at a consultation
A short list, worth bringing to any assessment: what is the diagnosis. What are the options, including doing nothing. Why this option over the others. What the full plan costs, once it has actually been assessed, not before. And for an itemised bill, so a medicine's price and a procedure's fee stay two separate, checkable figures rather than one number taken on trust.
None of those questions require confrontation, and a clinic that has thought about its own practice will usually answer them plainly. A price is one honest piece of a larger picture. The diagnosis is what tells you whether that piece belongs in your treatment at all.
